Training/PracticeHealth Policy and PromotionThe Transcatheter Aortic Valve Implantation (TAVI) Quality Report: A Call to Arms for Improving Quality in Canada
Section snippets
TAVI Procedures in Canada
Data obtained for the quality report spanned from April 2013 to March 2014. During that time period, 1122 patients were treated with TAVI for a national rate of 34 procedures per million inhabitants. There was considerable interprovincial variation in procedural volumes reflecting a disparity in access to care across the country, with 2 provinces having no local program (Saskatchewan and Newfoundland) at the time. Compared with other developed countries, in 2013 the rates of TAVI in Canada fell
TAVI Quality Indicators
The TAVI quality indicators were divided into 3 groups: structure, process, and outcomes (Fig. 1). The structure outcomes evaluated included documentation of: (1) a heart team recommendation for patients treated with TAVI; and (2) wait time for TAVI. A heart team recommendation was used in most centres (87.4%), illustrating appropriate collaboration between cardiology and cardiac surgery for optimal treatment decisions. This consensus is currently the standard of care for patients with aortic
Strengthening the Commitment to Quality
TAVI is increasingly becoming the standard of care for select patients while indications continue to broaden. The first CCS TAVI quality report shows that a national initiative to measure quality in cardiovascular care is feasible and valuable to clinicians, policy makers, and patients. This should serve as a “call to arms” to promote accountability, transparency, and quality assurance to improve the care of people treated with TAVI. We now have a unique opportunity to work collectively and in
Disclosures
The authors have no conflicts of interest to disclose.
References (5)
- et al.
Transcatheter aortic valve replacement in Europe: adoption trends and factors influencing device utilization
J Am Coll Cardiol
(2013) - et al.
Monitoring wait times for transcatheter aortic valve implantation: a need for national benchmarks
Can J Cardiol
(2014)
Cited by (13)
Regional Differences in Outcomes for Patients Undergoing Transcatheter Aortic Valve Replacement in New York State and Ontario
2023, Canadian Journal of CardiologyThe Safety of Early Discharge Following Transcatheter Aortic Valve Implantation Among Patients in Northern Ontario and Rural Areas Utilizing the Vancouver 3M TAVI Study Clinical Pathway
2022, CJC OpenCitation Excerpt :Despite the rise in the total number of TAVI procedures in Canada, the increase is not meeting the significant growth in demand due to the aging population and the expansion of TAVI indications to lower-risk populations.6 This problem is further compounded for patients that reside in rural areas, due to the inequity in access to TAVI that exists within Canada.6 Northern Ontario is an example of this, where issues exist pertaining to resource availability, program capacity, and limited TAVI funding allocation compared to centres in southern Ontario.
Quality-of-Life Outcomes After Transcatheter Aortic Valve Implantation in a “Real World” Population: Insights From a Prospective Canadian Database
2021, CJC OpenCitation Excerpt :There remains a significant gap between the consensus agreement that PROMs matter, and the availability of efficient and patient-centred electronic systems to collect, analyze, and report PROMs data in a timely and effective way.43 Overcoming these barriers with solutions tailored to the needs of the primarily older aortic stenosis population remains a challenge across Canadian jurisdictions.4 Our study should be interpreted in light of several limitations.
Precision Medicine in TAVR: How to Select the Right Device for the Right Patient
2021, Canadian Journal of CardiologyThe Dollars and Sense of Transcatheter Aortic Valve Replacement: An Example of the Benefit of Avoiding Stenoses in Health Care Services Research
2020, Canadian Journal of CardiologyInequity in Access to Transcatheter Aortic Valve Replacement: A Pan-Canadian Evaluation of Wait-Times
2020, Canadian Journal of Cardiology
See page 332 for disclosure information.